Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380179 · ClinicalTrials.gov registry record · NA
Photomedicine Project 14: PBMT for Performance Enhancement in SOF
A NA study of Performance Enhancement and Photobiomodulation Therapy, sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR).
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06380179: Recruiting NA study of Performance Enhancement and Photobiomodulation Therapy, sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR).
NCT06380179 is a NA study of Performance Enhancement and Photobiomodulation Therapy that is actively recruiting participants, run by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR). The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06380179, a NA study of Performance Enhancement and Photobiomodulation Therapy, is actively recruiting participants, sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR).
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Special Operations Forces (SOF) train continually to maintain peak performance. Thus, they are nearly always in a state of recovery, and in need of noninvasive therapies to address the taxing workload. Photobiomodulation therapy (PBMT) is a noninvasive treatment where a low-level laser is applied to the body to enhance healing, recovery, and performance. Army Tactical Human Optimization Rapid Rehabilitation and Reconditioning (THOR3) provides a consistent avenue for implementation of PBMT as a modality. Studies in athletes have shown performance and recovery benefits with pre-and post-workout focal application of PBMT. While there is less evidence on the potential cognitive/behavioral effects of a systematic application of PBMT, self-reported fatigue has also been found to be significantly lower in groups with focal PBMT application as compared to placebo. Further, PBMT research in healthy military tactical athletes is limited. PBMT may be a promising tool for enhancing physical performance by accelerating musculoskeletal and psychological recovery in the SOF population. The investigators aim to study the physiologic and behavioral effects of PBMT application post-exercise on performance in SOF Operators. The Intent: The investigators propose to conduct a single-blinded randomized-control trial with sham control to investigate the effectiveness of providing PBMT post physical training in a SOF population. The specific aims of this study are to: 1. Analyze and describe the physiologic effects, if any, of PBMT application post-exercise in Special Forces Operators undergoing coach-led training. 2. Analyze and describe the behavioral effects, if any, of PBMT application post-exercise in Special Forces Operators undergoing coach-led training. 3. Evaluate the overall clinical utility of focal PBMT subsequent to physical training in a US Army SOF, tactical athlete population.
Primary Outcome
Assesses dynamic strength performance, including concentric impulse via force plates and analysis software.
Conditions Studied
Interventions
- DEVICE THOR3 training + Photobiomodulation Therapy (PBMT)
- DEVICE THOR3 training + sham PBMT
Study Locations (1)
Washington
- Joint Base Lewis-McChord - Joint Base Lewis McChord
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2025-12 |
| Phase | NA |
Sponsor
Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR)1 total trials
What NCT06380179 shows while recruiting
NCT06380179 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 6 conditions, with Performance Enhancement appearing as the primary indexed condition, and to 2 interventions - of which THOR3 training + Photobiomodulation Therapy (PBMT) is the first listed.
NCT06380179 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06380179 about?
NCT06380179 is a clinical study titled "Photomedicine Project 14: PBMT for Performance Enhancement in SOF". Special Operations Forces (SOF) train continually to maintain peak performance. Thus, they are nearly always in a state of recovery, and in need of noninvasive therapies to address the taxing workload. Photobiomodulation therapy (PBMT) is a noninvasive treatment where a low-level laser is applied to...
What is the current status of trial NCT06380179?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2025-01-23. Estimated completion is 2025-12.
What conditions does trial NCT06380179 study?
This clinical trial studies the following conditions: Performance Enhancement, Photobiomodulation Therapy, Photomedicine, Low-Level Laser Therapy, Quadriceps.
What interventions are being tested in trial NCT06380179?
The interventions under investigation include: THOR3 training + Photobiomodulation Therapy (PBMT) (DEVICE), THOR3 training + sham PBMT (DEVICE).
Who is sponsoring clinical trial NCT06380179?
This trial is sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06380179 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Performance Enhancement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06380179's enrollment target sits among peer trials
116 808th of 2000 higher than 1,191 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI